These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 32274740)

  • 41. Heparanase-1-induced shedding of heparan sulfate from syndecan-1 in hepatocarcinoma cell facilitates lymphatic endothelial cell proliferation via VEGF-C/ERK pathway.
    Yu S; Lv H; Zhang H; Jiang Y; Hong Y; Xia R; Zhang Q; Ju W; Jiang L; Ou G; Zhang J; Wang S; Zhang J
    Biochem Biophys Res Commun; 2017 Apr; 485(2):432-439. PubMed ID: 28209511
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate.
    Escobar Galvis ML; Jia J; Zhang X; Jastrebova N; Spillmann D; Gottfridsson E; van Kuppevelt TH; Zcharia E; Vlodavsky I; Lindahl U; Li JP
    Nat Chem Biol; 2007 Dec; 3(12):773-8. PubMed ID: 17952066
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumor growth and metastasis.
    Sanderson RD; Yang Y; Suva LJ; Kelly T
    Matrix Biol; 2004 Oct; 23(6):341-52. PubMed ID: 15533755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heparan sulfate containing unsubstituted glucosamine residues: biosynthesis and heparanase-inhibitory activity.
    Nadanaka S; Purunomo E; Takeda N; Tamura J; Kitagawa H
    J Biol Chem; 2014 May; 289(22):15231-43. PubMed ID: 24753252
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of heparanase activity and heparanase-induced angiogenesis by suramin analogues.
    Marchetti D; Reiland J; Erwin B; Roy M
    Int J Cancer; 2003 Mar; 104(2):167-74. PubMed ID: 12569571
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Functions of Heparanase in Human Diseases.
    Jin H; Zhou S
    Mini Rev Med Chem; 2017; 17(6):541-548. PubMed ID: 27804885
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Soluble heparan sulfate fragments generated by heparanase trigger the release of pro-inflammatory cytokines through TLR-4.
    Goodall KJ; Poon IK; Phipps S; Hulett MD
    PLoS One; 2014; 9(10):e109596. PubMed ID: 25295599
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Heparanase Regulatory Network in Health and Disease.
    Mayfosh AJ; Nguyen TK; Hulett MD
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent advances in the discovery of heparanase inhibitors as anti-cancer agents.
    Jia L; Ma S
    Eur J Med Chem; 2016 Oct; 121():209-220. PubMed ID: 27240275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity.
    Levy-Adam F; Feld S; Cohen-Kaplan V; Shteingauz A; Gross M; Arvatz G; Naroditsky I; Ilan N; Doweck I; Vlodavsky I
    J Biol Chem; 2010 Sep; 285(36):28010-9. PubMed ID: 20576607
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New Advances of Heparanase and Heparanase-2 in Human Diseases.
    Jin H; Cui M
    Arch Med Res; 2018 Oct; 49(7):423-429. PubMed ID: 30850186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Histidine-rich glycoprotein binds heparanase and regulates its enzymatic activity and cell surface interactions.
    Poon IK; Yee DY; Jones AL; Wood RJ; Davis DS; Freeman C; Parish CR; Hulett MD
    Int J Biochem Cell Biol; 2010 Sep; 42(9):1507-16. PubMed ID: 20561914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heparanase procoagulant effects and inhibition by heparins.
    Nadir Y; Brenner B
    Thromb Res; 2010 Apr; 125 Suppl 2():S72-6. PubMed ID: 20434010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heparanase: Cloning, Function and Regulation.
    Gaskin SM; Soares Da Costa TP; Hulett MD
    Adv Exp Med Biol; 2020; 1221():189-229. PubMed ID: 32274711
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human heparanase nuclear localization and enzymatic activity.
    Schubert SY; Ilan N; Shushy M; Ben-Izhak O; Vlodavsky I; Goldshmidt O
    Lab Invest; 2004 May; 84(5):535-44. PubMed ID: 15034597
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An iminosugar-based heparanase inhibitor heparastatin (SF4) suppresses infiltration of neutrophils and monocytes into inflamed dorsal air pouches.
    Sue M; Higashi N; Shida H; Kogane Y; Nishimura Y; Adachi H; Kolaczkowska E; Kepka M; Nakajima M; Irimura T
    Int Immunopharmacol; 2016 Jun; 35():15-21. PubMed ID: 27015605
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heparanase procoagulant activity in cancer progression.
    Nadir Y; Brenner B
    Thromb Res; 2016 Apr; 140 Suppl 1():S44-8. PubMed ID: 27067977
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Implications of Heparan Sulfate and Heparanase in Amyloid Diseases.
    Li JP; Zhang X
    Adv Exp Med Biol; 2020; 1221():631-645. PubMed ID: 32274729
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
    Marchetti D; McQuillan DJ; Spohn WC; Carson DD; Nicolson GL
    Cancer Res; 1996 Jun; 56(12):2856-63. PubMed ID: 8665526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heparan Sulfate in the Tumor Microenvironment.
    Bartolini B; Caravà E; Caon I; Parnigoni A; Moretto P; Passi A; Vigetti D; Viola M; Karousou E
    Adv Exp Med Biol; 2020; 1245():147-161. PubMed ID: 32266657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.